MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway

Lei Yan1,2, Ruhao Zhou1,2, Yi Feng1,2

  • 1Second Clinical Medical College, Shanxi Medical University, 382 Wuyi Road, Taiyuan, Shanxi, 030001, China.

Cell Death Discovery
|April 25, 2024
PubMed

Insights

MicroRNAs (miRs), specifically miR-134-5p, inhibit osteosarcoma progression by downregulating the ITGB1/MMP2/PI3K/Akt pathway. Lower miR-134-5p levels correlate with increased tumor malignancy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNAs (miRs) play crucial roles in various cellular processes, including tumorigenesis.
  • Osteosarcoma (OS) is a prevalent bone cancer in adolescents, but the specific roles of miRs in its development are not fully understood.

Purpose of the Study:

  • To investigate the role and mechanism of miR-134-5p in osteosarcoma progression.
  • To determine if miR-134-5p can be a therapeutic target for osteosarcoma.

Main Methods:

  • Quantitative real-time PCR to measure miR-134-5p expression in OS tissues and cells.
  • In vitro assays to assess the effects of miR-134-5p on OS cell proliferation, migration, invasion, and vasculogenic mimicry.
  • Western blotting to analyze the expression of proteins in the ITGB1/MMP2/PI3K/Akt pathway.

Main Results:

  • miR-134-5p was significantly downregulated in osteosarcoma tissues and cells compared to normal controls.
  • Overexpression of miR-134-5p suppressed OS cell proliferation, migration, invasion, and vasculogenic mimicry.
  • Knockdown of miR-134-5p promoted these malignant behaviors.
  • miR-134-5p inhibited the expression of the ITGB1/MMP2/PI3K/Akt signaling axis.

Conclusions:

  • miR-134-5p acts as a tumor suppressor in osteosarcoma by inhibiting the ITGB1/MMP2/PI3K/Akt pathway.
  • miR-134-5p holds potential as a therapeutic target for osteosarcoma treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K